Delivery Order SPE2DB22D9316-SPE2DB25FYN45
Award Date
2/25/25
Potential Completion Date
3/18/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of STELARA 130 MG/26 ML VIAL 26ML, a specialized pharmaceutical product, with a total ceiling value of $7,574.76 and a performance period through January 27, 2025. The contract is a firm fixed-price delivery order and is not associated with any set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of STELARA 90 MG/ML SYRINGE for a total ceiling value of $49,324.08. It is a firm fixed-price delivery order contract with a period of performance ending on March 13, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,930.42 firm fixed-price contract is for the provision of STELARA 90 MG/ML SYRINGE, a specialized biologic medication. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its small business status to secure this direct award from the DLA. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,324.08 firm fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,730.56, is for the delivery of STELARA 130 MG/26 ML VIAL 26ML, a specialty pharmaceutical product. The contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which enables...
This is a firm fixed-price delivery order (SPE2DB20D6037|SPE2DB25FTUG2) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,195.95 contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,730.56 contract was awarded by the Defense Logistics Agency (DLA) to provide a 130 mg/26 ml vial of the pharmaceutical product STELARA. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical items...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,538.62 award is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, to support the medical needs of the Department of Defense (DoD). This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,435.20, is for the delivery of the pharmaceutical product STELARA 130 MG/26 ML VIAL 26ML. This order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at up to $499,999,999, which allows the DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,992.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract is for the supply of STELARA 90 MG/ML SYRINGE, a biologic medication, with an ultimate completion date of March 28, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA, valued up to $4,999,999, that enables the...